Condition: Response, Acute Phase · Survivorship · Sponsor: Hospital General de Mexico
Retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination.
This description comes directly from the study's public registry record.
Christian O Ramos Peñafiel, PhD · +52 55 27892000 · leukemiachop33@gmail.com
Adán G Gallardo Rodriguez, PhD · +52 55 27892000 · nutriologo.agallardo8@gmail.com
Always discuss trial participation with your own doctor first.
| Hospital General de Mexico Dr. Eduardo Liceaga | Mexico City, Mexico City, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06284395